title: Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: beta-blockers and prostate cancer survival--interpretation of competing risks models.
authors.forename: Krishnan
authors.initials: K
authors.lastname: Bhaskaran
authors.forename: Bernard
authors.initials: B
authors.lastname: Rachet
authors.forename: Stephen
authors.initials: S
authors.lastname: Evans
authors.forename: Liam
authors.initials: L
authors.lastname: Smeeth
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D000319:Adrenergic beta-Antagonists